About MicroRx Infectious Disease Supercluster Personnel COO - Opgenorth CSO - Beaty TSM - Headley General Inquiry Contact Information Advisory Northern Colorado Infectious Disease Research Downloadable Documents MicroRx Brochure Infectious Disease Supercluster Featured Research Facilities and Resources Partnering Featured Research Emerging Pathogen Threats Food Safety Mycobacterial Disease Vector-borne Disease Resources Animal Models Product Development and Manufacturing Research Innovation Center Intellectual Property For Researchers Supercluster Activities Cluster Leaders Technology Transfer Process Legal Agreements CDA's Consulting IDF Contact Us Email Registration General Inquiry

MicroRx Technologies           MicroRx ID   Title of Technology   06-022   Menaquinone A Inhibitors: Anti Mycobacterial Agents                   06-032   Serodiagnostic Antigens for Tuberculosis                   07-003   A Toll Receptor 2 Directed TB Vaccine                   07-037   Acid and Base Stable Esters: New Linkers for Solid-Phase Organic Synthesis (Synthesis or Libraries)                   07-050   Validation of a Rapid Diagnostic Test for Strangles                   07-053   Transferrin Receptor and Ferritin Expression in Primary Lung Lesions of Tuberculosis                   07-059   Identification and Characterization of Deliverable RNA Aptamers That Block Late Stage of HIV-1 Replication                   08-010   Asymmetrically Substituted Thiourea Derivatives: Potential Anti-TB Therapeutic Agents                   07-069M   A Drug-Sensitized Pseudomonas Aeruginosa Strain Useful for Drug Discovery                   08-012   Improved Diagnostic Methods for M. Tuberculosis and M. Leprae                   97-037   Early Detection of Tuberculosis Using Culture Filtrate Proteins of Mycobacterium tuberculosis in Serological Assays

Copyright © 2007 MicroRx. All rights reserved.